Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Oncopeptides in connection with a directed share issue (2)
Mandate

Vinge advises Oncopeptides in connection with a directed share issue

January 25, 2019 Capital Markets and Public M&A

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 546 million, before issue costs.

The share issue is directed to a number of selected international and Swedish reputable investors and life sciences specialist investors, on the basis of an accelerated bookbuilding process conducted by Jefferies International Limited, Carnegie Investment Bank AB (publ) and DNB Markets, a part of DNB Bank ASA.

Oncopeptides is a clinical development pharmaceutical company focused on conducting anti cancer research to develop treatments for the benefit of patients. The company’s shares are admitted to trading on Nasdaq Stockholm.

Vinge’s team has consisted of Dain Hård Nevonen, Johan Winnerblad, Rikard Lindahl and Hampus Olsson.

Related

Vinge advises Active Biotech in connection with rights issue

 Vinge advises Active Biotech AB (publ) in connection with a rights issue of approximately SEK 43 million.
November 29, 2024

Vinge advises ABGSC and SEB in connection with Europi’s inaugural issuance of green bonds

Vinge has advised the joint arrangers in connection with Europi Property Group AB (publ)’s (the "Company") inaugural issue of EUR 50 million senior unsecured green bonds within a framework of up to EUR 100 million. The bonds carry a floating interest rate of EURIBOR 3M + 5.00% and have a tenor of three years. The Company intends to apply for admission to trading of the new bonds on Nasdaq Transfer Market and the sustainable bond list of Nasdaq Stockholm.
November 29, 2024

Vinge advises Rieber & Søn in connection with its acquisition of Accept Försäkringsaktiebolag (publ)

 Accept, with headquarter in Stockholm, has been an innovator in the Swedish insurance market since its formation in 1998. The company was the first with offering loss of income insurance and has since offered products that complement the general insurance offering. Today, Accept delivers web-based insurance solutions customised for its offering.
November 21, 2024